Replies to post #107082 on WEALTH UNIVERSITY

[spencer_has_arrived]

Well,... I have tried playing it twice in the last month or so and each time I just didn't have my focus on it properly or didn't let it play thru.
I bought it the first time at 2.00 level and they dropped it on me ...my running stop hit and at the end of the day I checked it and it blew up over $4.00...Imagine how I felt.

But i digress ......they are a buyout candidate, they have a $5.00 price target, they are a biotech and as such susceptible to capitol raises at the drop of a hat,long months with no news, sudden incredible rises of pps and crashes.
Other than that here is what
briefing. com said about them in recent inplay's....

01-Sep-09 07:09 ET In Play EDAP TMS SA reports Q2 EPS of (EUR0.05) vs (EUR0.15) single est; revs up 37% YoY to EUR6.8 mln vs the EUR5.55 mln single est (3.96 ) :
31-Aug-09 10:56 ET In Play EDAP TMS SA pops to session highs; Hearing move attributed to chatter that positive commentary on its Sonolith drug from a large pharma co is expected (4.34 +0.46) -Update :
27-Aug-09 10:05 ET In Play EDAP TMS SA jumps ~$0.50 over past 15 minutes; hearing strength attributed to takeover chatter (4.15 +0.74) -Update :
20-Aug-09 11:12 ET In Play EDAP TMS SA tgt raised to $5 at Roth following FDA approval of its Sonolith I-Sys lithotripsy device (4.35 +0.15) : Roth raises their EDAP tgt to $5 from $2.50, given the news yesteday that the FDA cleared its 510(k) application for the Sonolith I-Sys lithotripsy device, allowing the co to market the system in the US. The firm believes that the co's upcoming entrance into the US market should allow it to establish an account base to launch its Ablatherm HIFU prostate therapy device upon approval. In the firm's opinion, this announcement is a milestone for EDAP, as it represents the company's first US FDA cleared product. In addition, the firm believes that patients and physicians prefer non-invasive procedures to surgical alternatives due to the shorter recovery time and lower cost, which should benefit EDAP.

As for me ...biotechs scare the hell out of me. When you get in early and they get hot...you can become rich. Like i said today i made $8000.000 on AVII today.
But when you get bagged you are stuck. CYTR still has some of money....4 months later.

[serpico1127]

I'm averaged in EDAP at about $4.10. Haven't really decided what I'll do with it though. Decent chance I'll sell tomorrow AM on a gap up. Too much volatility on those Lion plays, not to mention the fact that it's already had a run of 225% in the last two weeks. I don't know how much more people can realistically expect from it in the near term. Just my opinion though!